Breaking News Instant updates and real-time market news.

JELD

Jeld-Wen

$24.08

-0.22 (-0.91%)

12:52
10/07/18
10/07
12:52
10/07/18
12:52

Jeld-Wen announces rulings in Steves & Sons litigation

Jeld-Wen announced that the U.S. District Court for the Eastern District of Virginia, Richmond Division, has recently issued a number of rulings in the company's ongoing antitrust and trade secrets litigation with Steves & Sons. First, the District Court entered judgment against Steves in the amount of $1.2M, in accordance with the previously announced jury verdict in Jeld-Wen's favor on its claims that Steves misappropriated Jeld-Wen's trade secrets. Second, the District Court granted Jeld-Wen's motion to vacate the jury verdict on Steves' breach of contract claims related to the quality of the company's doorskins. This ruling eliminates $2.2M of damages under the previously announced jury verdict on Steves' breach of contract claims against Jeld-Wen. Lastly, the District Court ruled that divestiture of the company's facility in Towanda, Pennsylvania, the primary asset acquired in Jeld-Wen's 2012 acquisition of CraftMaster and one of the company's four domestic doorskin manufacturing facilities, is an appropriate remedy in the antitrust litigation. A final judgment on the antitrust claims and the breach of contract claims has not yet been entered in the case, and the company does not expect a final judgment until later this year. Jeld-Wen intends to vigorously oppose entry of an adverse judgment and to appeal any judgment that may be entered awarding damages to the Steves. The company expects that the next procedural step in the case will be a final determination of remedies, following which the Court will enter judgment. Under the ruling, if divestiture of the Towanda facility is included in the final judgment, such a divestiture would not be required until sometime after the appeal process is complete. The initial appeal process is expected to take approximately 9-18 months following entry of a final judgment. Should an appeal to the U.S. Supreme Court be necessary, the appeal process would be extended by an additional 6-18 months. The company continues to believe that any remedy requiring the company to sell the Towanda facility is both unprecedented and fundamentally incorrect as a matter of law. Jeld-Wen believes that both the jury verdict on Steves' breach of contract and antitrust claims and the rulings on those claims are incorrect due to multiple flawed rulings during the trial process. These rulings improperly limited the company's defenses in the trial by excluding key evidence and other relevant matters from the jury's consideration. Evidence that the company was prevented from presenting to the jury included the favorable results of the two previous DOJ antitrust enforcement reviews, the significant profitability growth and expansion of Steves' own business since the 2012 acquisition, and other benefits to the market resulting from the combination of Jeld-Wen and CMI. Finally, the company maintains that a potential remedy of divestiture in this matter is contrary to established legal and equitable principles due to the significant passage of time since the acquisition, Steves' own misconduct in misappropriating Jeld-Wen's trade secrets and the availability of monetary remedies. For the fiscal year ended 2017, the Towanda facility generated external revenues of approximately $120M from Steves and other third-party customers related to doorskins and other building products. The company continues to supply doorskins to Steves in the ordinary course of business pursuant to a long-term agreement that is currently set to terminate in September 2021. The company is unable to predict the ultimate timing of, transaction terms, or proceeds from any divestiture of the Towanda facility. In the event that a divestiture is ultimately required, Jeld-Wen expects the Towanda facility to be sold to an independent third-party buyer, in which case the company expects to meet its internal requirements for doorskins currently supplied by the Towanda facility through other existing internal sources of supply and from a supply agreement with the new owner.

JELD Jeld-Wen
$24.08

-0.22 (-0.91%)

09/26/18
MACQ
09/26/18
INITIATION
MACQ
Outperform
Jeld-Wen initiated with an Outperform at Macquarie
09/26/18
09/26/18
INITIATION
Target $35

Outperform
Macquarie starts 'best self-help story' Jeld-Wen at Outperform at Macquarie
As previously reported, Macquarie analyst Adam Baumgarten initiated Jeld-Wen with an Outperform rating, calling it the "best self-help story in building products." Given the steps already taken to improve interior door pricing dynamics and an experienced restructuring veteran now in charge, Baumgarten sees a "very positive" risk/reward, he tells investors. He set a $35 price target on Jeld-Wen shares.
10/02/18
GSCO
10/02/18
INITIATION
Target $31
GSCO
Buy
Jeld-Wen initiated with a Buy at Goldman Sachs
Goldman Sachs analyst Doug Clark started Jeld-Wen with a Buy rating and $31 price target. The analyst rolled out coverage on the Building Products sector with Neutral rating.
10/02/18
GSCO
10/02/18
INITIATION
Target $31
GSCO
Buy
Jeld-Wen initiated with a Buy at Goldman Sachs
Goldman Sachs analyst Doug Clark initiated Owens Corning with a Buy and $31 price target saying new CEO leadership provides a clear catalyst with the company planning to provide detail around margin improvements, potentially including manufacturing optimization and rationalization of the foot print.

TODAY'S FREE FLY STORIES

FSFG

First Savings Financial Group

$51.33

0.22 (0.43%)

17:31
02/22/19
02/22
17:31
02/22/19
17:31
Hot Stocks
First Savings Financial raises quarterly dividend to 16c per share from 15c »

The dividend will be paid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$110.97

1.5 (1.37%)

17:31
02/22/19
02/22
17:31
02/22/19
17:31
Periodicals
Employees demand Microsoft cancel $480M U.S. Army contract, Reuters says »

Several Microsoft workers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 01

    Mar

  • 03

    Mar

  • 04

    Mar

  • 06

    Mar

  • 07

    Mar

  • 18

    Mar

ENT

Global Eagle

$2.66

(0.00%)

17:23
02/22/19
02/22
17:23
02/22/19
17:23
Hot Stocks
Global Eagle to cut workforce by roughly 15% »

As previously disclosed,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

17:15
02/22/19
02/22
17:15
02/22/19
17:15
General news
Breaking General news story  »

New York Federal Reserve…

NOC

Northrop Grumman

$288.84

2.54 (0.89%)

17:13
02/22/19
02/22
17:13
02/22/19
17:13
Hot Stocks
Northrop Grumman exec Kalan sells 4,312 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYB

LyondellBasell

$89.14

0.63 (0.71%)

17:07
02/22/19
02/22
17:07
02/22/19
17:07
Syndicate
Breaking Syndicate news story on LyondellBasell »

LyondellBasell files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCCO

Technical Comm Corp

$2.76

0.17 (6.56%)

17:06
02/22/19
02/22
17:06
02/22/19
17:06
Hot Stocks
Technical Comm Corp to submit plan to regain compliance with Nasdaq by March 4 »

Technical Comm Corp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INFU

InfuSystem

$4.15

0.04 (0.97%)

17:01
02/22/19
02/22
17:01
02/22/19
17:01
Hot Stocks
InfuSystem announces settlement of derivative lawsuit »

InfuSystem Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KALU

Kaiser Aluminum

$108.22

-1.9 (-1.73%)

17:01
02/22/19
02/22
17:01
02/22/19
17:01
Hot Stocks
Kaiser Aluminum names Neal West as new CFO »

Kaiser Aluminum announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALDR

Alder Biopharmaceuticals

$14.35

0.19 (1.34%)

17:00
02/22/19
02/22
17:00
02/22/19
17:00
Hot Stocks
Alder Biopharmaceuticals submits eptinezumab BLA to FDA »

Alder BioPharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

RF

Regions Financial

$16.24

-0.01 (-0.06%)

16:59
02/22/19
02/22
16:59
02/22/19
16:59
Syndicate
Breaking Syndicate news story on Regions Financial »

Regions Financial files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

HL

Hecla Mining

$2.59

-0.145 (-5.31%)

16:58
02/22/19
02/22
16:58
02/22/19
16:58
Syndicate
Breaking Syndicate news story on Hecla Mining »

Hecla Mining files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$50.99

0.84 (1.68%)

, CELG

Celgene

$89.15

0.54 (0.61%)

16:52
02/22/19
02/22
16:52
02/22/19
16:52
Hot Stocks
Bristol-Myers files proxy statement in connection with proposed Celgene merger »

Bristol-Myers Squibb…

BMY

Bristol-Myers

$50.99

0.84 (1.68%)

CELG

Celgene

$89.15

0.54 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 28

    Feb

  • 18

    May

  • 20

    May

  • 28

    May

TEN

Tenneco

$36.29

0.76 (2.14%)

16:48
02/22/19
02/22
16:48
02/22/19
16:48
Earnings
Tenneco sees FY19 revenue growth up 4%-5%, consensus $4.65B »

The company expects 2019…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

TEN

Tenneco

$36.29

0.76 (2.14%)

16:46
02/22/19
02/22
16:46
02/22/19
16:46
Earnings
Tenneco reports preliminary Q4 revenue $4.3B, consensus $4.3B »

Sees FY18 EPS "near…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

XRX

Xerox

$31.50

0.16 (0.51%)

16:44
02/22/19
02/22
16:44
02/22/19
16:44
Conference/Events
Xerox management to meet with Loop Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

TWTR

Twitter

$31.70

0.94 (3.06%)

16:38
02/22/19
02/22
16:38
02/22/19
16:38
Hot Stocks
Twitter board member Evan Williams to step down at end of month »

On February 22, 2019,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

ALLY

Ally Financial

$26.95

-0.07 (-0.26%)

16:34
02/22/19
02/22
16:34
02/22/19
16:34
Hot Stocks
Ally Financial CEO sells over 97,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Mar

  • 28

    May

DAL

Delta Air Lines

$51.52

0.04 (0.08%)

16:33
02/22/19
02/22
16:33
02/22/19
16:33
Hot Stocks
Delta Air Lines' West sells 36,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REN

Resolute Energy

$31.61

0.09 (0.29%)

16:30
02/22/19
02/22
16:30
02/22/19
16:30
Hot Stocks
Resolute Energy stockholders approve merger with Cimarex Energy »

Resolute Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

16:30
02/22/19
02/22
16:30
02/22/19
16:30
Options
Preliminary option volume of 18.8M today »

Preliminary option volume…

ORI

Old Republic

$21.14

0.04 (0.19%)

16:22
02/22/19
02/22
16:22
02/22/19
16:22
Hot Stocks
Old Republic raises quarterly dividend to 20c from 19.5c per share »

This dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
02/22/19
02/22
16:20
02/22/19
16:20
Options
Closing CBOE SPX and VIX Index summary for February 22nd »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
02/22/19
02/22
16:17
02/22/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFC

Ellington Financial

$16.97

-0.01 (-0.06%)

16:16
02/22/19
02/22
16:16
02/22/19
16:16
Hot Stocks
Ellington Financial to convert to a Delaware corporation »

Ellington Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.